Cognitive trajectories diverge by genetic risk in a preclinical longitudinal cohort

Abstract

AbstractINTRODUCTIONWe sought to characterize the timing of changes in cognitive trajectories related to genetic risk using the apolipoprotein E (APOE) score, a continuous measure of Alzheimer's disease (AD) risk. We also aimed to determine whether that timing was different when genetic risk was measured using an AD polygenic risk score (PRS) that contains APOE.METHODSWe analyzed trajectories (N ≈1135) for four neuropsychological composite scores using mixed effects regression for longitudinal change across APOE scores and PRS of participants in the Wisconsin Registry for Alzheimer's Prevention, a longitudinal study of adults aged 40 to 70 at baseline, with a median participant follow‐up time of 7.8 years.RESULTSWe found a significant non‐linear age‐by‐APOE score interaction in predicting cognitive decline. Cognitive trajectories diverged by APOE score at approximately 65 years of age. A 0.5 standard deviation difference in cognition between extreme percentiles of the PRS was predicted to occur 1 to 2 years before that of the APOE score.DISCUSSIONCognitive decline differs across time and APOE score. Estimates did not substantially shift with the AD PRS.Highlights The apolipoprotein E (APOE) score, a continuous measure, accounts for non‐linear genetic risk of Alzheimer's disease. Non‐linear age interacts with the APOE score to affect cognition. Cognitive decline starts to differ by APOE score levels at approximately age 65. Cognitive decline timing by polygenic risk (including APOE) is similar to APOE alone.